SCHEMBL18491

SCHEMBL18491

CC#C[Mg]Cl

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17771 0.60
SCHEMBL3202652 0.60
SCHEMBL14677044 0.58
SCHEMBL16967 0.58
Magnesium Chloride Anhydrous SCHEMBL29243117 0.55
Magnesium Chloride Anhydrous SCHEMBL28918542 0.55
Acetonitrile SCHEMBL28248166 0.55
SCHEMBL18681 0.52
SCHEMBL3994247 0.52
SCHEMBL2052 0.51

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 57 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025242747-A1 MULTI -COMPONENT FORMULATIONS OF ORGANOMETALLIC REAGENTS MERCK PATENT GMBH (DE) 2025-11-27 WO claimed
EP-0102531-B1 PROCESS FOR THE PREPARATION OF COMPOUNDS OF THE MEGASTIGMAN-SERIES, AND INTERMEDIATES FOR THIS SYNTHESIS BASF Aktiengesellschaft (DE) 1988-03-02 EP claimed
WO-2025242747-A1 MULTI -COMPONENT FORMULATIONS OF ORGANOMETALLIC REAGENTS MERCK PATENT GMBH (DE) 2025-11-27 WO disclosed
US-20250179004-A1 PROCESSES AND INTERMEDIATES FOR PREPARING MCL1 INHIBITORS GILEAD SCIENCES, INC. 2025-06-05 US disclosed
US-12202782-B2 Processes and intermediates for preparing MCL1 inhibitors GILEAD SCIENCES, INC. (US) 2025-01-21 US disclosed
EP-4247783-A1 PROCESSES AND INTERMEDIATES FOR PREPARING MACROCYCLIC MCL1 INHIBITORS GILEAD SCIENCES, INC. (US) 2023-09-27 EP disclosed
US-20220177409-A1 PROCESSES AND INTERMEDIATES FOR PREPARING MCL1 INHIBITORS GILEAD SCIENCES, INC. 2022-06-09 US disclosed
WO-2022108984-A1 PROCESSES AND INTERMEDIATES FOR PREPARING MACROCYCLIC MCL1 INHIBITORS GILEAD SCIENCES, INC. (US) 2022-05-27 WO disclosed
US-10975094-B2 Heterocyclic compounds as RSV inhibitors ENANTA PHARMACEUTICALS, INC. (US) 2021-04-13 US disclosed
US-10696686-B2 Herbicidally active (alkynyl-phenyl)-substituted cyclic dione compounds and derivatives thereof SYNGENTA LIMITED (GB) 2020-06-30 US disclosed
US-10662138-B2 Herbicidal propynyl-phenyl compounds SYNGENTA PARTICIPATIONS AG (CH) 2020-05-26 US disclosed
US-20070191389-A1 Biaryl derivatives BANYU PHARMACEUTICAL CO., LTD. (JP) 2007-08-16 US disclosed
EP-1764362-A1 BIARYL DERIVATIVES BANYU PHARMACEUTICAL CO., LTD. (JP) 2007-03-21 EP disclosed
EP-1549627-A1 1-PHENYLALKYL-PIPERAZINES Recordati Ireland Limited (IE) 2005-07-06 EP disclosed
US-20040072839-A1 1-Phenylalkylpiperazines RECORDATI S.A. (CH) 2004-04-15 US disclosed
WO-2003106443-A1 1-PHENYLALKYL-PIPERAZINES RECORDATI S.A. (CH) 2003-12-24 WO disclosed
EP-0145493-B1 11-DIFLUOROMETHYL AND 11-FLUOROMETHYLENE STEROIDS THE UPJOHN COMPANY (US) 1989-03-08 EP disclosed
US-4557867-A CONTRACEPTIVES THE UPJOHN COMPANY (US) 1985-12-10 US disclosed
EP-0145493-A2 11-Difluoromethyl and 11-fluoromethylene steroids THE UPJOHN COMPANY (US) 1985-06-19 EP disclosed
EP-0102531-A2 Process for the preparation of compounds of the megastigman-series, and intermediates for this synthesis BASF Aktiengesellschaft (DE) 1984-03-14 EP disclosed